Rheumatoid Arthritis Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Rheumatoid Arthritis Market to 2027 - Global Analysis and Forecasts By Molecule Type (Pharmaceuticals and Biologics & Biosimilars); Product (Prescription and Over-the-Counter (OTC)); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)

Report Code: TIPRE00003490 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Rheumatoid arthritis (RA) is a chronic inflammatory disease, which generally leads to disability, progressive joint deformity, and occasionally premature death. RA may affect many tissues and organs, but it principally attacks the joints, producing an inflammatory synovitis that often progresses to destruction of the articular cartilage and ankylosis of the joints. The treatment options available for rheumatoid arthritis are nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs) and biologic response modifiers (biologics).

MARKET DYNAMICS
The rheumatoid arthritis market is anticipated to grow in the forecast period owing to driving factors such as rise in prevalence of arthritis, increasing acceptance of biopharmaceuticals, and presence of well-defined regulatory guidelines in developed economies. However, the accessibility of the treatment, patent expiration of blockbuster drugs and alternative treatment options for rheumatoid arthritis are projected to hamper the market growth.

MARKET SCOPE
The "Global Rheumatoid Arthritis Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of rheumatoid arthritis market with detailed market segmentation by molecule type, product, distribution channel and geography. The global rheumatoid arthritis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading rheumatoid arthritis market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global rheumatoid arthritis market is segmented on the basis of molecule type, product and distribution channel. Based on molecule type, the market is segmented as pharmaceuticals and biologics & biosimilars. The rheumatoid arthritis market, based on product is segmented into prescription and over-the-counter (OTC). By distribution channel the rheumatoid arthritis market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global rheumatoid arthritis market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The rheumatoid arthritis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting rheumatoid arthritis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the rheumatoid arthritis market in these regions.

MARKET PLAYERS
The reports cover key developments in the rheumatoid arthritis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from rheumatoid arthritis market are anticipated to lucrative growth opportunities in the future with the rising demand for rheumatoid arthritis market in the global market. Below mentioned is the list of few companies engaged in the rheumatoid arthritis market.

The report also includes the profiles of key rheumatoid arthritis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AbbVie
  • Boehringer Ingelheim GmbH
  • Novartis
  • Regeneron Pharmaceuticals Inc.
  • Pfizer, Inc.
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson Services, Inc.
  • UCB S.A.
  • Amgen Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rheumatoid Arthritis Market - By Molecule Type
1.3.2 Rheumatoid Arthritis Market - By Product
1.3.3 Rheumatoid Arthritis Market - By Distribution Channel
1.3.4 Rheumatoid Arthritis Market - By Region
1.3.4.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. RHEUMATOID ARTHRITIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. RHEUMATOID ARTHRITIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. RHEUMATOID ARTHRITIS MARKET - GLOBAL MARKET ANALYSIS
6.1. RHEUMATOID ARTHRITIS - GLOBAL MARKET OVERVIEW
6.2. RHEUMATOID ARTHRITIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. RHEUMATOID ARTHRITIS MARKET - REVENUE AND FORECASTS TO 2027 - MOLECULE TYPE
7.1. OVERVIEW
7.2. MOLECULE TYPE MARKET FORECASTS AND ANALYSIS
7.3. PHARMACEUTICALS
7.3.1. Overview
7.3.2. Pharmaceuticals Market Forecast and Analysis
7.3.3. NSAIDs Market
7.3.3.1. Overview
7.3.3.2. NSAIDs Market Forecast and Analysis
7.3.4. Analgesics Market
7.3.4.1. Overview
7.3.4.2. Analgesics Market Forecast and Analysis
7.3.5. Glucocorticoids Market
7.3.5.1. Overview
7.3.5.2. Glucocorticoids Market Forecast and Analysis
7.3.6. Others Market
7.3.6.1. Overview
7.3.6.2. Others Market Forecast and Analysis
7.4. BIOLOGICS & BIOSIMILARS
7.4.1. Overview
7.4.2. Biologics & Biosimilars Market Forecast and Analysis

8. RHEUMATOID ARTHRITIS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. PRESCRIPTION
8.3.1. Overview
8.3.2. Prescription Market Forecast and Analysis
8.4. OVER-THE-COUNTER (OTC)
8.4.1. Overview
8.4.2. Over-the-Counter (OTC) Market Forecast and Analysis

9. RHEUMATOID ARTHRITIS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis

10. RHEUMATOID ARTHRITIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Rheumatoid Arthritis Market Overview
10.1.2 North America Rheumatoid Arthritis Market Forecasts and Analysis
10.1.3 North America Rheumatoid Arthritis Market Forecasts and Analysis - By Molecule Type
10.1.4 North America Rheumatoid Arthritis Market Forecasts and Analysis - By Product
10.1.5 North America Rheumatoid Arthritis Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Rheumatoid Arthritis Market Forecasts and Analysis - By Countries
10.1.6.1 United States Rheumatoid Arthritis Market
10.1.6.1.1 United States Rheumatoid Arthritis Market by Molecule Type
10.1.6.1.2 United States Rheumatoid Arthritis Market by Product
10.1.6.1.3 United States Rheumatoid Arthritis Market by Distribution Channel
10.1.6.2 Canada Rheumatoid Arthritis Market
10.1.6.2.1 Canada Rheumatoid Arthritis Market by Molecule Type
10.1.6.2.2 Canada Rheumatoid Arthritis Market by Product
10.1.6.2.3 Canada Rheumatoid Arthritis Market by Distribution Channel
10.1.6.3 Mexico Rheumatoid Arthritis Market
10.1.6.3.1 Mexico Rheumatoid Arthritis Market by Molecule Type
10.1.6.3.2 Mexico Rheumatoid Arthritis Market by Product
10.1.6.3.3 Mexico Rheumatoid Arthritis Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Rheumatoid Arthritis Market Overview
10.2.2 Europe Rheumatoid Arthritis Market Forecasts and Analysis
10.2.3 Europe Rheumatoid Arthritis Market Forecasts and Analysis - By Molecule Type
10.2.4 Europe Rheumatoid Arthritis Market Forecasts and Analysis - By Product
10.2.5 Europe Rheumatoid Arthritis Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Rheumatoid Arthritis Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Rheumatoid Arthritis Market
10.2.6.1.1 Germany Rheumatoid Arthritis Market by Molecule Type
10.2.6.1.2 Germany Rheumatoid Arthritis Market by Product
10.2.6.1.3 Germany Rheumatoid Arthritis Market by Distribution Channel
10.2.6.2 France Rheumatoid Arthritis Market
10.2.6.2.1 France Rheumatoid Arthritis Market by Molecule Type
10.2.6.2.2 France Rheumatoid Arthritis Market by Product
10.2.6.2.3 France Rheumatoid Arthritis Market by Distribution Channel
10.2.6.3 Italy Rheumatoid Arthritis Market
10.2.6.3.1 Italy Rheumatoid Arthritis Market by Molecule Type
10.2.6.3.2 Italy Rheumatoid Arthritis Market by Product
10.2.6.3.3 Italy Rheumatoid Arthritis Market by Distribution Channel
10.2.6.4 Spain Rheumatoid Arthritis Market
10.2.6.4.1 Spain Rheumatoid Arthritis Market by Molecule Type
10.2.6.4.2 Spain Rheumatoid Arthritis Market by Product
10.2.6.4.3 Spain Rheumatoid Arthritis Market by Distribution Channel
10.2.6.5 United Kingdom Rheumatoid Arthritis Market
10.2.6.5.1 United Kingdom Rheumatoid Arthritis Market by Molecule Type
10.2.6.5.2 United Kingdom Rheumatoid Arthritis Market by Product
10.2.6.5.3 United Kingdom Rheumatoid Arthritis Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Rheumatoid Arthritis Market Overview
10.3.2 Asia-Pacific Rheumatoid Arthritis Market Forecasts and Analysis
10.3.3 Asia-Pacific Rheumatoid Arthritis Market Forecasts and Analysis - By Molecule Type
10.3.4 Asia-Pacific Rheumatoid Arthritis Market Forecasts and Analysis - By Product
10.3.5 Asia-Pacific Rheumatoid Arthritis Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Rheumatoid Arthritis Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Rheumatoid Arthritis Market
10.3.6.1.1 Australia Rheumatoid Arthritis Market by Molecule Type
10.3.6.1.2 Australia Rheumatoid Arthritis Market by Product
10.3.6.1.3 Australia Rheumatoid Arthritis Market by Distribution Channel
10.3.6.2 China Rheumatoid Arthritis Market
10.3.6.2.1 China Rheumatoid Arthritis Market by Molecule Type
10.3.6.2.2 China Rheumatoid Arthritis Market by Product
10.3.6.2.3 China Rheumatoid Arthritis Market by Distribution Channel
10.3.6.3 India Rheumatoid Arthritis Market
10.3.6.3.1 India Rheumatoid Arthritis Market by Molecule Type
10.3.6.3.2 India Rheumatoid Arthritis Market by Product
10.3.6.3.3 India Rheumatoid Arthritis Market by Distribution Channel
10.3.6.4 Japan Rheumatoid Arthritis Market
10.3.6.4.1 Japan Rheumatoid Arthritis Market by Molecule Type
10.3.6.4.2 Japan Rheumatoid Arthritis Market by Product
10.3.6.4.3 Japan Rheumatoid Arthritis Market by Distribution Channel
10.3.6.5 South Korea Rheumatoid Arthritis Market
10.3.6.5.1 South Korea Rheumatoid Arthritis Market by Molecule Type
10.3.6.5.2 South Korea Rheumatoid Arthritis Market by Product
10.3.6.5.3 South Korea Rheumatoid Arthritis Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Rheumatoid Arthritis Market Overview
10.4.2 Middle East and Africa Rheumatoid Arthritis Market Forecasts and Analysis
10.4.3 Middle East and Africa Rheumatoid Arthritis Market Forecasts and Analysis - By Molecule Type
10.4.4 Middle East and Africa Rheumatoid Arthritis Market Forecasts and Analysis - By Product
10.4.5 Middle East and Africa Rheumatoid Arthritis Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Rheumatoid Arthritis Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Rheumatoid Arthritis Market
10.4.6.1.1 South Africa Rheumatoid Arthritis Market by Molecule Type
10.4.6.1.2 South Africa Rheumatoid Arthritis Market by Product
10.4.6.1.3 South Africa Rheumatoid Arthritis Market by Distribution Channel
10.4.6.2 Saudi Arabia Rheumatoid Arthritis Market
10.4.6.2.1 Saudi Arabia Rheumatoid Arthritis Market by Molecule Type
10.4.6.2.2 Saudi Arabia Rheumatoid Arthritis Market by Product
10.4.6.2.3 Saudi Arabia Rheumatoid Arthritis Market by Distribution Channel
10.4.6.3 U.A.E Rheumatoid Arthritis Market
10.4.6.3.1 U.A.E Rheumatoid Arthritis Market by Molecule Type
10.4.6.3.2 U.A.E Rheumatoid Arthritis Market by Product
10.4.6.3.3 U.A.E Rheumatoid Arthritis Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Rheumatoid Arthritis Market Overview
10.5.2 South and Central America Rheumatoid Arthritis Market Forecasts and Analysis
10.5.3 South and Central America Rheumatoid Arthritis Market Forecasts and Analysis - By Molecule Type
10.5.4 South and Central America Rheumatoid Arthritis Market Forecasts and Analysis - By Product
10.5.5 South and Central America Rheumatoid Arthritis Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Rheumatoid Arthritis Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Rheumatoid Arthritis Market
10.5.6.1.1 Brazil Rheumatoid Arthritis Market by Molecule Type
10.5.6.1.2 Brazil Rheumatoid Arthritis Market by Product
10.5.6.1.3 Brazil Rheumatoid Arthritis Market by Distribution Channel
10.5.6.2 Argentina Rheumatoid Arthritis Market
10.5.6.2.1 Argentina Rheumatoid Arthritis Market by Molecule Type
10.5.6.2.2 Argentina Rheumatoid Arthritis Market by Product
10.5.6.2.3 Argentina Rheumatoid Arthritis Market by Distribution Channel

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. RHEUMATOID ARTHRITIS MARKET, KEY COMPANY PROFILES
12.1. ABBVIE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM GMBH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. REGENERON PHARMACEUTICALS INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BRISTOL-MYERS SQUIBB
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. F. HOFFMANN-LA ROCHE AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JOHNSON AND JOHNSON SERVICES, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. UCB S.A.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AMGEN INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie
2. Boehringer Ingelheim GmbH
3. Novartis
4. Regeneron Pharmaceuticals Inc.
5. Pfizer, Inc.
6. Bristol-Myers Squibb
7. F. Hoffmann-La Roche Ltd
8. Johnson & Johnson Services, Inc.
9. UCB S.A.
10. Amgen Inc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book